Peptide

CJC-1295

Overview

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that increases growth hormone and IGF-1 levels. Available with or without DAC (Drug Affinity Complex), it promotes muscle growth, fat loss, and improved recovery. Often combined with Ipamorelin.

Dosage

With DAC: 2mg per week, Without DAC: 100-200mcg 2-3x per day

Cycle Length

8-12 weeks

Benefits

  • Increased growth hormone levels
  • Enhanced muscle growth
  • Improved fat loss
  • Better sleep quality
  • Enhanced recovery
  • Improved skin elasticity
  • Increased bone density
  • Anti-aging effects

Side Effects

  • Water retention
  • Numbness or tingling
  • Increased hunger
  • Headaches
  • Injection site irritation
  • Possible insulin resistance
  • Elevated prolactin (rare)

Post Cycle Therapy (PCT)

No PCT required

⚠️ Warning: This information is for educational purposes only. Consult with a healthcare professional before use.